Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities-Reference-Cited by-同舟云学术

Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities

Published:2015-03-06 Issue:9 Volume:56 Page:2552-2555
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Sevindik Omur Gokmen,Guc Zeynep,Kahraman Selda,Medeni Solmaz Serife,Katgi Abdullah,Acar Celal,Alacacioglu Inci,Piskin Ozden,Ozsan Guner Hayri,Demirkan Fatih,Undar Bulent,Ozcan Mehmet Ali

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2015.1014362

Reference33 articles.

1. International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

2. Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic Syndromes

3. Comorbidity Considerations in Geriatric Oncology Research

4. The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome

5. Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome;Frontiers in Nutrition;2023-03-07

2. The Circular RNA Circ-ANAPC7 as a Biomarker for the Risk Stratification of Myelodysplastic Syndrome;Indian Journal of Hematology and Blood Transfusion;2022-11-18

3. The Utility of CONUT Score in Diffuse Large B Cell Lymphoma Patients;Nigerian Journal of Clinical Practice;2021

4. The geriatric nutritional risk index predicts the early death and survival in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia‐related changes treated with azacitidine;Hematological Oncology;2020-06-24

5. Does the platelet‑to‑lymphocyte ratio have a prognostic effect in patients with myelodysplastic syndrome?;Bratislava Medical Journal;2020